Jinxin Fertility Group Limited (JXR) disclosed a fresh on-market repurchase of 1.38 million ordinary shares on 10 September 2026, according to its latest Next Day Disclosure Return filed with the Hong Kong Stock Exchange.

Key transaction details • Volume: 1.38 million shares, equal to 0.05% of JXR’s issued share capital (excluding treasury shares) as at 9 September 2026. • Price range: HKD 2.155–2.200 per share, with a volume-weighted average of HKD 2.1686. • Aggregate consideration: HKD 2.99 million. • Repurchased shares are being held as treasury stock; none were cancelled on the transaction date.

Share capital movement • Issued shares (excluding treasury shares) decreased from 2.69 billion to 2.69 billion after the repurchase, while treasury shares rose from 16.20 million to 17.57 million. • Total issued shares remained unchanged at 2.71 billion.

Outstanding repurchases pending cancellation Between 27 March and 25 August 2026, JXR bought back 67.66 million shares for cancellation that had not yet been cancelled as of 10 September 2026. Transaction prices for these lots ranged from HKD 1.97 to HKD 2.47 per share, with individual parcel sizes spanning 0.80–8.00 million shares.

Repurchase mandate utilisation • Shareholders authorised JXR on 25 June 2026 to repurchase up to 262.51 million shares. • Including the latest transaction, 30.12 million shares—approximately 1.15% of the company’s issued share capital on the mandate date—have been repurchased under this authority. • In line with Hong Kong listing rules, JXR is subject to a moratorium on issuing new shares or disposing of treasury shares until 10 October 2026.

Governance statement The company affirmed that all repurchases were executed on the Exchange in accordance with the Hong Kong Main Board Listing Rules and that no material changes have been made to the explanatory statement filed on 2 June 2026.